Patents by Inventor Naveen Bhatnagar

Naveen Bhatnagar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230374062
    Abstract: Disclosed herein are methods galatosylating IgG antibodies, methods of preparing hypersialylated (hsIgG), e.g., using immobilized ?1,4-Galactosyltransferase I (?4GalT1), as well as polypeptides comprising ?1,4-Galactosyltransferase I (?4GalT1) bound to a solid support and compositions comprising the same.
    Type: Application
    Filed: March 4, 2021
    Publication date: November 23, 2023
    Inventors: Naveen Bhatnagar, James Meador, III
  • Publication number: 20210277438
    Abstract: Glycoproteins having particular sialylation patterns, and methods of making and using such glycoproteins, are described.
    Type: Application
    Filed: November 20, 2020
    Publication date: September 9, 2021
    Inventors: Naveen Bhatnagar, Robin Meccariello, Jonathan C. Lansing, Daniel Ortiz, Hetal Sarvaiya, Nathaniel J. Washburn
  • Publication number: 20210040527
    Abstract: Glycoproteins having particular sialylation patterns, and methods of making and using such glycoproteins, are described.
    Type: Application
    Filed: September 25, 2020
    Publication date: February 11, 2021
    Inventors: Naveen Bhatnagar, Robin Meccariello, Jonathan C. Lansing, Daniel Ortiz, Hetal Sarvaiya, Nathaniel J. Washburn
  • Publication number: 20210017563
    Abstract: Glycoproteins having particular sialylation patterns, and methods of making and using such glycoproteins, are described.
    Type: Application
    Filed: September 25, 2020
    Publication date: January 21, 2021
    Inventors: Naveen Bhatnagar, Robin Meccariello, Jonathan C. Lansing, Daniel Ortiz, Hetal Sarvaiya, Nathaniel J. Washburn
  • Publication number: 20200032312
    Abstract: Glycoproteins having particular sialylation patterns, and methods of making and using such glycoproteins, are described.
    Type: Application
    Filed: October 1, 2019
    Publication date: January 30, 2020
    Inventors: Naveen Bhatnagar, Robin Meccariello, Jonathan C. Lansing, Daniel Ortiz, Hetal Sarvaiya, Nathaniel J. Washburn
  • Patent number: 10377809
    Abstract: Sulfated glycoproteins, and methods of making and using such sulfated glycoproteins, are described.
    Type: Grant
    Filed: April 10, 2017
    Date of Patent: August 13, 2019
    Assignee: Momenta Pharmaceuticals, Inc.
    Inventors: Dorota A. Bulik, Carlos J. Bosques, Brian Edward Collins, Maurice Gaston Hains, Nathaniel J. Washburn, James Meador, Sean Smith, Naveen Bhatnagar
  • Patent number: 10377832
    Abstract: Modified glycoproteins, and methods of making and using such modified glycoproteins, are described.
    Type: Grant
    Filed: April 25, 2017
    Date of Patent: August 13, 2019
    Assignee: Momenta Pharmaceuticals, Inc.
    Inventors: Nathaniel Washburn, James Meador, III, Carlos J. Bosques, Dorota A. Bulik, Naveen Bhatnagar, Julia Brown, Lynn Markowitz, Sathya Prabbhakar
  • Publication number: 20180305725
    Abstract: Glycoproteins having particular sialylation patterns, and methods of making and using such glycoproteins, are described.
    Type: Application
    Filed: April 16, 2018
    Publication date: October 25, 2018
    Inventors: Naveen Bhatnagar, Robin Meccariello, Jonathan C. Lansing, Daniel Ortiz, Hetal Sarvaiya, Nathaniel Washburn
  • Publication number: 20170349662
    Abstract: Modified glycoproteins, and methods of making and using such modified glycoproteins, are described.
    Type: Application
    Filed: April 25, 2017
    Publication date: December 7, 2017
    Inventors: Nathaniel Washburn, James Meador, III, Carlos J. Bosques, Dorota A. Bulik, Naveen Bhatnagar, Julia Brown, Lynn Markowitz, Sathya Prabbhakar
  • Publication number: 20170247426
    Abstract: Sulfated glycoproteins, and methods of making and using such sulfated glycoproteins, are described.
    Type: Application
    Filed: April 10, 2017
    Publication date: August 31, 2017
    Inventors: Dorota A. Bulik, Carlos J. Bosques, Brian Edward Collins, Maurice Gaston Hains, Nathaniel J. Washburn, James Meador, Sean Smith, Naveen Bhatnagar
  • Patent number: 9663581
    Abstract: Modified glycoproteins, and methods of making and using such modified glycoproteins, are described.
    Type: Grant
    Filed: April 24, 2013
    Date of Patent: May 30, 2017
    Assignee: Momenta Pharmaceuticals, Inc.
    Inventors: Nathaniel Washburn, James Meador, III, Carlos J. Bosques, Dorota A. Bulik, Naveen Bhatnagar, Julia Brown, Lynn Markowitz, Sathya Prabbhakar
  • Patent number: 9650433
    Abstract: Sulfated glycoproteins, and methods of making and using such sulfated glycoproteins, are described.
    Type: Grant
    Filed: May 18, 2012
    Date of Patent: May 16, 2017
    Assignee: Momenta Pharmaceuticals, Inc.
    Inventors: Dorota A. Bulik, Carlos J. Bosques, Brian Edward Collins, Maurice Gaston Hains, Nathaniel J. Washburn, James Meador, Sean Smith, Naveen Bhatnagar
  • Publication number: 20160108450
    Abstract: Glycoproteins having particular sialylation patterns, and methods of making and using such glycoproteins, are described.
    Type: Application
    Filed: May 1, 2014
    Publication date: April 21, 2016
    Inventors: Naveen BHATNAGAR, Robin MECCARIELLO, Jonathan C. LANSING, Daniel ORTIZ, Hetal SARVAIYA, Nathaniel WASHBURN
  • Publication number: 20150299331
    Abstract: Modified glycoproteins, and methods of making and using such modified glycoproteins, are described.
    Type: Application
    Filed: April 24, 2013
    Publication date: October 22, 2015
    Inventors: Nathaniel Washburn, James Meador, III, Carlos J. Bosques, Dorota A. Bulik, Naveen Bhatnagar, Julia Brown, Lynn Markowitz, Sathya Prabbhakar
  • Patent number: 9139876
    Abstract: Methods for analyzing mixtures of polysaccharides, for example heparin such as unfractionated heparin and enoxaparin are described. In some instances, the mixtures are analyzed using high performance liquid chromatography (HPLC), e.g., reverse phase HPLC.
    Type: Grant
    Filed: May 2, 2008
    Date of Patent: September 22, 2015
    Assignee: MOMENTA PHARMACUETICALS, INC.
    Inventors: Zachary Shriver, Naveen Bhatnagar, Nur Sibel Gunay, Jennifer Ozug, Elaine Y. Sun
  • Publication number: 20150252108
    Abstract: Preparations of glycoproteins, e.g., therapeutic preparations of glycoproteins, having altered levels of affinity for Fc? receptors relative to reference glycoprotein preparations, and methods of making and methods of using such preparations, are described.
    Type: Application
    Filed: September 25, 2013
    Publication date: September 10, 2015
    Applicant: Momenta Pharmaceuticals, Inc.
    Inventors: Nathaniel J. Washburn, Jonathan C. Lansing, Carlos J. Bosques, Naveen Bhatnagar, Dorota A. Bulik, Lynn Markowitz, Sandra Sipsey
  • Publication number: 20140112910
    Abstract: Sulfated glycoproteins, and methods of making and using such sulfated glycoproteins, are described.
    Type: Application
    Filed: May 18, 2012
    Publication date: April 24, 2014
    Applicant: MOMENTA PHARMACEUTICALS, INC.
    Inventors: Dorota A. Bulik, Carlos J. Bosques, Brian Edward Collins, Maurice Gaston Hains, Nathaniel J. Washburn, James Meador, Sean Smith, Naveen Bhatnagar
  • Publication number: 20130123126
    Abstract: A method of making a glycoprotein having a selected glycostructure.
    Type: Application
    Filed: April 7, 2011
    Publication date: May 16, 2013
    Applicant: MOMENTA PHARMACEUTICALS, INC.
    Inventors: Brian Edward Collins, Jay Duffner, Victor Farutin, Naveen Bhatnagar, Lakshmanan Thiruneelakantapillai, Carlos J. Bosques, Ganesh Kaundinya